Search Prime Grants

R01DA059291

Project Grant

Overview

Grant Description
Unraveling the intersection of substance use, inflammation, and HIV via hair levels - project summary/abstract

Given the overlapping syndemics of HIV and HIV risk with substance use and the contribution of both HIV and substance use to chronic inflammation, robust, objective metrics to quantitate the type, amount, and patterns of substance use are needed.

Self-reported metrics are limited by social desirability bias, where individuals report behavior desired by the provider or researcher, and recall bias, especially with the use of memory-altering substances.

The UCSF Hair Analytical Laboratory (HAL) has been involved in developing objective adherence metrics in the field of HIV for 20 years, showing the utility of analyzing antiretroviral treatment (ART) levels in hair samples to assess ART and pre-exposure prophylaxis (PrEP) adherence and exposure.

The UCSF HAL has also developed hair measures of anti-tuberculosis (TB) drugs. Given the critical importance of assessing substance use accurately, and the impact of substances on HIV outcomes, including inflammation, this proposal aims to direct our laboratory's technical expertise to the field of substance use monitoring.

Although available for forensics as qualitative (yes/no) metrics, hair levels assessing quantitative use of multiple substances have not been widely available for substance use-HIV studies. Polysubstance use is common and quantitative multi-analyte metrics allow impacts on adherence and systemic inflammation to be assessed.

Harnessing an important NIDA-funded cohort study investigating substance use in those with or at risk of HIV (the MStudy cohort), this proposal aims to develop a suite of hair assays for substances in the UCSF HAL for NIH-funded research studies investigating substance use, HIV, and inflammation.

A single multi-analyte panel to simultaneously measure substances (e.g. methamphetamines, different opiates, cocaine, cannabis, tobacco, and others) will allow intentional or unintentional polysubstance use to be quantitated.

The MStudy has enrolled a biobehavioral cohort since 2013 of over 500 young men who have sex with men (MSM) of color, half as active substance users (279 with and 278 without HIV) in Los Angeles.

The robust specimen biorepository of MStudy contains 76,000 biological samples, with 1115 hair samples from 319 MStudy participants who report use of methamphetamine, ecstasy, cocaine, heroin, fentanyl, and/or cannabis. Hair sample collection was initiated in August 2014 and is ongoing.

These hair samples will serve as the basis of developing and validating the methods for a multi-analyte panel of substances in hair in the UCSF HAL (Aim 1); analyzing the relationship between hair levels and self-reported adherence measures, urine toxicology screens, and clinical outcomes (Aim 2); and assessing the relationship between hair levels (of single or multiple substances) and biomarkers of inflammation (Aim 3).

Via this proposal, the UCSF HAL aims to become the reference laboratory to provide quantitative, objective metrics of substance use exposure in hair samples for multiple studies examining the interaction between substance use and HIV.
Funding Goals
NOT APPLICABLE
Place of Performance
San Francisco, California 941102859 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 292% from $774,688 to $3,034,322.
San Francisco Regents Of The University Of California was awarded Quantitative Substance Use Monitoring HIV Studies: Hair Level Analysis Project Grant R01DA059291 worth $3,034,322 from National Institute on Drug Abuse in July 2023 with work to be completed primarily in San Francisco California United States. The grant has a duration of 4 years 10 months and was awarded through assistance program 93.279 Drug Abuse and Addiction Research Programs. The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 6/5/26

Period of Performance
7/1/23
Start Date
5/31/28
End Date
60.0% Complete

Funding Split
$3.0M
Federal Obligation
$0.0
Non-Federal Obligation
$3.0M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to R01DA059291

Transaction History

Modifications to R01DA059291

Additional Detail

Award ID FAIN
R01DA059291
SAI Number
R01DA059291-572373655
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75N600 NIH National Insitute on Drug Abuse
Funding Office
75N600 NIH National Insitute on Drug Abuse
Awardee UEI
KMH5K9V7S518
Awardee CAGE
4B560
Performance District
CA-11
Senators
Dianne Feinstein
Alejandro Padilla

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute on Drug Abuse, National Institutes of Health, Health and Human Services (075-0893) Health research and training Grants, subsidies, and contributions (41.0) $774,688 100%
Modified: 6/5/26